Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 13/20 | 0.91 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.57 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.54 |
| ▸ | PHLPP1 | O60346 | 1/20 | 0.54 |
| ▸ | ILK | Q13418 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.52 |
| ▸ | TTPA | P49638 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9356622 | 1.00 | AKT1 (0.91) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL21408660 | 1.00 | AKT1 (0.91) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL14273379 | 1.00 | AKT1 (0.91) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL29920786 | 1.00 | AKT1 (0.91) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL74101 | 1.00 | AKT1 (0.91) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL23295126 | 1.00 | AKT1 (0.91) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| Benzene SCHEMBL6653333 | 0.98 | AKT1 (0.87) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL15441415 | 0.95 | AKT1 (1.00) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| Acetic Acid SCHEMBL9356676 | 0.95 | AKT1 (0.81) | AKT1LMNANR1I2PDPK1PHLPP1 | |
| SCHEMBL9356878 | 0.91 | AKT1 (0.74) | AKT1LMNANR1I2PDPK1PHLPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115135323-A | Pharmaceutical composition | 深圳市药欣生物科技有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-11447459-B2 | Use of substituted chroman-6-ols with extended lipophilic side chains | DSM IP ASSETS B.V. (NL) | 2022-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11447459-B2 | Use of substituted chroman-6-ols with extended lipophilic side chains | FFAR3, C1S, FFAR1 | AKT1 988/4885LMNA 2165/4885NR1I2 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.